Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Latest Activist Moves Made by Jeffrey Smith, Paul Singer, More

Page 1 of 2

Numerous financial news websites and stock market participants call activist investors “vultures”, who aim to extract short-term benefits at the expense of companies’ long-term performance. But I don’t think for an instant that reputable activist Carl Icahn and some of his peers share a short-term vision. On the contrary, numerous activists, including Icahn, have pushed for changes or proposed new strategies aimed at increasing efficiency and creating long-term value, and hold onto their investments for years. Of course, there are some players in the hedge fund industry who focus on a short-term horizon and seek short-term value extraction, but the shareholder activism arena has changed quite dramatically over the years. Leaving the controversy about the benefits and detriments of shareholder activism aside, let’s take a look at three 13D (activist) filings recently submitted by activists Jeffrey Smith, Paul Singer, and Brad Gerstner.

Imitating hedge funds and other institutional investors can help identify some of the most profitable stocks on the market. However, our extensive research that covered the period between 1999 and 2012, showed that the best approach is to follow these investors into their small-cap stocks. Our backtests showed that the 15 most popular small-cap stocks among hedge funds managed to generate a monthly alpha of 81 basis points, versus an alpha of 0.7 percentage points posted by their top 50 large-cap picks (see more details here).

According to a newly-amended 13D filing, Jeffrey Smith’s Starboard Value LP currently owns 42.28 million shares of Quantum Corp (NYSE:QTM), which constitute 14.8% of the company’s outstanding common stock. The filing discloses that the activist hedge fund has sold exactly 5.0 million shares over the past 60 days or so. It should be mentioned that Jeffrey C. Smith had served as a member of the company’s Board of Directors from 2013 through May 2015, when he announced his resignation. Upon Mr. Smith’s resignation, Quantum Corp (NYSE:QTM)’s CEO claimed that the activist investor “has been an integral part of our recent accomplishments and has helped to put the company on a path to long-term profitable growth and value creation”, though this statement is not entirely reflected in the company’s stock performance.

The expert in scale-out storage, archive and data protection has seen its shares decline by more than 50% since Jeffrey Smith joined the Board in May 2013. Moreover, the stock has lost 60% over the last year alone and trades at a forward price-to-earnings multiple of 9.56, which is substantially below the average of 15.38 for the S&P 500 family. Quantum’s total revenue for the first six months of fiscal year 2015 that ended September 30 totaled $227.88 million, down by 13.4% year-over-year. The decrease can be explained by the changing storage environment, which is defined by increasing demand for scale-out storage solutions and softening demand for data protection tape products. For that reason, the company’s goal for fiscal year 2016 includes driving up scale-out storage revenue and focusing on enhancing profitability. The smart money sentiment towards the stock was negative in the third quarter, as the number of hedge funds in our system with positions in the company declined to 17 from 24 quarter-over-quarter. Peter S. Park’s Park West Asset Management owns 9.32 million shares of Quantum Corp (NYSE:QTM) as of September 30.

Jeffrey Smith
Jeffrey Smith
Starboard Value LP

Let’s move on to the next page of this article, where we discuss the other two 13D filings submitted with the SEC.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!